CD8A and neoplasm: Our results demonstrated that Ampk-KO tumor cells up-regulated the expression of PD1 and TIM3 on CD8+ T cells, which were inhibited by STS, while Pdl1-KO tumor cells reduced the elevated expression of PD1 and TIM3 on CD8+ T cells induced by Ampk-KO (Figure S2C-S2D).